-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UUAqSQXoAh/ENDN2cb9o++OWluOdTyO9Tvn5pE7QouHxdg/x/FRwH+mmcgcGoLqA
 888Geephi6eFASw1jc74UA==

<SEC-DOCUMENT>0000846475-04-000004.txt : 20040217
<SEC-HEADER>0000846475-04-000004.hdr.sgml : 20040216
<ACCEPTANCE-DATETIME>20040217164659
ACCESSION NUMBER:		0000846475-04-000004
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20031231
FILED AS OF DATE:		20040217
EFFECTIVENESS DATE:		20040217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX MEDICAL HOLDINGS   INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-26787-D
		FILM NUMBER:		04609541

	BUSINESS ADDRESS:	
		STREET 1:		4766 HOLLADAY
		STREET 2:		BLVD.
		CITY:			HOLLADAY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		8012739300

	MAIL ADDRESS:	
		STREET 1:		SHERRY MCEVOY
		STREET 2:		848 RAINBOW BLVD 221
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARIZONA VENTURES INC
		DATE OF NAME CHANGE:	20030115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHINA GLOBAL DEVELOPMENT INC
		DATE OF NAME CHANGE:	20020130
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>latenote.htm
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY TEXT="#000000" LINK="#0000ff" VLINK="#551a8b" ALINK="#ff0000" BGCOLOR="#FFFFFF">

<hr size="6" color="#0000FF">

<P>               &nbsp;</P>

<P align="center">               <b>               U.S. SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON D.C. 20549</b></P>

<BR WP="BR1">FORM 12b-25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
SEC File Number: <strong>0 27323&nbsp;</strong><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CUSIP Number:<U><FONT FACE=""><FONT SIZE="-1">0065983262</FONT></FONT></U>
<P align="center">                     <b><font size="5">                     NOTIFICATION OF LATE FILING</font></b>					</P>

<BR WP="BR1">                             (Check One):<br>
[ ] Form 10-K&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[ ] Form 11-K&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[ ] Form 20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[x ] Form 10-QSB<BR WP="BR2">
<P>     For Period Ended:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December
31,&nbsp; 2003</P>

<hr color="#0000FF">

<BR WP="BR1">Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.  Nothing in this Form shall be construed to imply
that the Commission has verified any information contained herein.
<hr color="#0000FF">
<P>     If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification
relates</P>

<hr color="#0000FF">
<P align="center"><b>PART I-REGISTRANT INFORMATION</b></P>

<hr color="#0000FF">
<P>     Full Name of Registrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><font size="4">&nbsp;&nbsp;&nbsp;&nbsp;Zynex
Medical Holdings, Inc</font></b><STRONG><FONT SIZE="+1"><U><br>
</U></FONT>
</STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P>     &nbsp;&nbsp; Former Name if Applicable&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT SIZE="+1"><STRONG>
Arizona Ventures, Inc.
</STRONG></FONT></U></P>

<hr color="#0000FF">
<P>     Address of Principal Executive Office, (Street and Number)</P>

<P><STRONG><U><FONT SIZE="+1">4766 Holladay Blvd ,</FONT></U></STRONG></P>

<hr color="#0000FF">
<P>     City, State and Zip Code</P>

<P>                         <STRONG><U><FONT SIZE="+1">Holladay, Utah 84117</FONT></U> </STRONG><BR WP="BR2">
</P>

<hr color="#0000FF">
<P align="center"><b>PART II-RULES 12B-25 (B) AND (C)</b></P>

<hr color="#0000FF">
<P>     If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed.  (Check box if appropriate)		</P>

<P>     [ ]  a.   The reasons described in reasonable detail in Part III of this form could not be eliminated without
unreasonable effort or expense;</P>

<P>     [X]  b.   The subject annual report or semi-annual report/portion thereof will be filed on or before
the fifteenth calendar day following the prescribed due date; or the subject quarterly report/portion
thereof will be filed on or before the fifth calendar day following the prescribed due date; and&nbsp;

<BR WP="BR1"><BR WP="BR2">
     [ ]  c.   The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if
applicable.</P>

<hr color="#0000FF">
<P align="center"><b>PART III-NARRATIVE</b></P>

<hr color="#0000FF">
<P>      The Company accountant needs additional time to complete the complied accounting
information to file a complete and accurate statement.</P>

<hr color="#0000FF">
<P align="center"><b>PART IV-OTHER INFORMATION</b></P>

<hr color="#0000FF">
<P>     1.   Name and telephone number of person to contact in regard to this notification</P>

<P>	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Nathan Drage   (801) 273-9300    </P>

<P>     2.   Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange
Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required to file such
report(s) been filed?  If the answer is no, identify&nbsp; report(s).</P>

<P>                          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[X] Yes     [ ] No</P>

<P>     3.   Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings statements
to be included in the subject report or&nbsp; portion thereof?</P>

<P>                          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[ ] Yes     [x ] No</P>

<P>          If so:  attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons  why a reasonable estimate of the
results can not be made.<BR WP="BR2">
</P>

<P align="center"><strong><u><font size="+1">Zynex Medical Holdings, Inc.<br>
</font></u></strong>(Name of Registrant as specified in charter)</P>

<BR WP="BR1">has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
<p>

<BR WP="BR1"><BR WP="BR2">

<P>Date:&nbsp; February 13, 2004</P>

<P> By_____/s/____________________________<br>
Dean Becker</P>

<P>INSTRUCTION:  The form may be signed by an executive officer of the registrant or by any other duly authorized representative  The name
and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on
behalf of the registrant shall be filed with the form.</P>

<hr color="#0000FF" size="6">

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
